Bruce Rutherford
Director/Board Member at Dentigenix, Inc.
Bruce Rutherford active positions
Companies | Position | Start | End |
---|---|---|---|
Dentigenix, Inc.
Dentigenix, Inc. BiotechnologyHealth Technology Dentigenix, Inc. develops tissue engineering, stem cell, and dental biological products. The company was founded by Christopher P. Somogyi on January 21, 2003 and is headquartered in Seattle, WA. | Director/Board Member | - | - |
Career history of Bruce Rutherford
Former positions of Bruce Rutherford
Companies | Position | Start | End |
---|---|---|---|
Dentigenix, Inc.
Dentigenix, Inc. BiotechnologyHealth Technology Dentigenix, Inc. develops tissue engineering, stem cell, and dental biological products. The company was founded by Christopher P. Somogyi on January 21, 2003 and is headquartered in Seattle, WA. | Corporate Officer/Principal | - | - |
Novalar Pharmaceuticals, Inc.
Novalar Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Novalar Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. It focuses on dental products. The company's OraVerse product (phentolamine mesylate) reverses the effects of local anesthetic with a vasoconstrictor and accelerates the return of normal sensation and function. The company was founded in 2000 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 01/01/2006 | - |
Training of Bruce Rutherford
University of Washington | Undergraduate Degree |
Rochester Christian University | Doctorate Degree |
Statistics
International
United States | 5 |
Operational
Corporate Officer/Principal | 2 |
Undergraduate Degree | 1 |
Doctorate Degree | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Novalar Pharmaceuticals, Inc.
Novalar Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Novalar Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. It focuses on dental products. The company's OraVerse product (phentolamine mesylate) reverses the effects of local anesthetic with a vasoconstrictor and accelerates the return of normal sensation and function. The company was founded in 2000 and is headquartered in San Diego, CA. | Health Technology |
Dentigenix, Inc.
Dentigenix, Inc. BiotechnologyHealth Technology Dentigenix, Inc. develops tissue engineering, stem cell, and dental biological products. The company was founded by Christopher P. Somogyi on January 21, 2003 and is headquartered in Seattle, WA. | Health Technology |
- Stock Market
- Insiders
- Bruce Rutherford
- Experience